{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:38:15Z","timestamp":1793914695574,"version":"4.8.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004243","name":"prinses beatrix spierfonds","doi-asserted-by":"publisher","award":["WAR 08-24"],"award-info":[{"award-number":["WAR 08-24"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004243","name":"prinses beatrix spierfonds","doi-asserted-by":"publisher","award":["13-07"],"award-info":[{"award-number":["13-07"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004243","name":"prinses beatrix spierfonds","doi-asserted-by":"publisher","award":["14-26"],"award-info":[{"award-number":["14-26"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013428","name":"stichting spieren voor spieren","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Respiratory complications are the most important cause of morbidity and mortality in spinal muscular atrophy (SMA). Respiratory muscle weakness results in impaired cough, recurrent respiratory tract infections and eventually can cause respiratory failure. We assessed longitudinal patterns of respiratory muscle strength in a national cohort of treatment-na\u00efve children and adults with SMA, hypothesizing a continued decline throughout life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We measured maximal expiratory and inspiratory pressure (PE\n                      <jats:sub>max<\/jats:sub>\n                      and PI\n                      <jats:sub>max<\/jats:sub>\n                      ), Sniff Nasal inspiratory pressure (SNIP), peak expiratory flow (PEF), and peak cough flow (PCF) in treatment-na\u00efve patients with SMA. We used mixed-models to analyze natural history patterns.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We included 2172 measurements of respiratory muscle function from 80 treatment-na\u00efve patients with SMA types 1c-3b. All outcomes were lower in the more severe phenotypes. Significant differences in PEF were present between SMA types from early ages onwards. PEF decline was linear (1\u20132%\/year). PEF reached values below 80% during early childhood in types 1c-2, and during adolescence in type 3a. PE\n                      <jats:sub>max<\/jats:sub>\n                      and PI\n                      <jats:sub>max<\/jats:sub>\n                      were severely lowered in most patients throughout life, with PE\n                      <jats:sub>max<\/jats:sub>\n                      values abnormally low (i.e. &lt;\u200980 cmH\n                      <jats:sub>2<\/jats:sub>\n                      O) in virtually all patients. The PE\n                      <jats:sub>max<\/jats:sub>\n                      \/PI\n                      <jats:sub>max<\/jats:sub>\n                      ratio was &lt;\u20091 throughout life in all SMA types, indicating that expiratory muscles were most affected. All but SMA type 3b patients had a lowered PCF. Patients with types 2b and 3a had PCF levels between 160 and 270\u00a0L\/min, those with type 2a around 160\u00a0L\/min and patients with type 1c well below 160\u00a0L\/min. Finally, SNIP was low in nearly all patients, most pronounced in more severely affected patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There are clear differences in respiratory muscle strength and its progressive decline between SMA types. We observed lower outcomes in more severe SMA types. Particularly PEF may be a suitable outcome measure for the follow-up of respiratory strength in patients with SMA. PEF declines in a rather linear pattern in all SMA types, with clear differences at baseline. These natural history data may serve as a reference for longer-term treatment efficacy assessments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-022-02227-7","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T13:10:51Z","timestamp":1645449051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Natural history of respiratory muscle strength in spinal muscular atrophy: a prospective national cohort study"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2918-9989","authenticated-orcid":false,"given":"Esther S.","family":"Veldhoen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camiel A.","family":"Wijngaarde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik H. J.","family":"Hulzebos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roelie M.","family":"W\u00f6sten-van Asperen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renske I.","family":"Wadman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben P. A.","family":"van Eijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fay Lynn","family":"Asselman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marloes","family":"Stam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise A. M.","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Cuppen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feline E. V.","family":"Scheijmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura P. Verweij-van","family":"den Oudenrijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Gaytant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis K.","family":"van der Ent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Ludo","family":"van der Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"issue":"3","key":"2227_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","volume":"28","author":"RS Finkel","year":"2018","unstructured":"Finkel RS, Mercuri E, Meyer OH, Simonds AK, Schroth MK, Graham RJ, et al. Diagnosis and management of spinal muscular atrophy: Part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord. 2018;28(3):197\u2013207.","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"2227_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1474-4422(12)70061-3","volume":"11","author":"E Mercuri","year":"2012","unstructured":"Mercuri E, Bertini E, Iannaccone ST. Childhood spinal muscular atrophy: controversies and challenges. Lancet Neurol. 2012;11(5):443\u201352.","journal-title":"Lancet Neurol"},{"issue":"18","key":"2227_CR3","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017;377(18):1723\u201332.","journal-title":"N Engl J Med"},{"issue":"7","key":"2227_CR4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","volume":"378","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Darras BT, Chiriboga CA, Day JW, Campbell C, Connolly AM, et al. Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med. 2018;378(7):625\u201335.","journal-title":"N Engl J Med"},{"issue":"18","key":"2227_CR5","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377(18):1713\u201322.","journal-title":"N Engl J Med"},{"issue":"2","key":"2227_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy: Part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28(2):103\u201315.","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"2227_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1212\/WNL.0000000000006026","volume":"91","author":"BT Darras","year":"2018","unstructured":"Darras BT, De Vivo DC. Precious SMA natural history data: a benchmark to measure future treatment successes. Neurology. 2018;91(8):337\u20139.","journal-title":"Neurology"},{"issue":"1","key":"2227_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13023-020-01367-y","volume":"15","author":"CA Wijngaarde","year":"2020","unstructured":"Wijngaarde CA, Veldhoen ES, Van Eijk RPA, Stam M, Otto LAM, Asselman FL, et al. Natural history of lung function in spinal muscular atrophy. Orphanet J Rare Dis. 2020;15(1):88.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2227_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1164\/rccm.200512-1841OC","volume":"174","author":"F Nicot","year":"2006","unstructured":"Nicot F, Hart N, Forin V, Le Boul\u00e9 M, Cl\u00e9ment A, Polkey MI, et al. Respiratory muscle testing: a valuable tool for children with neuromuscular disorders. Am J Respir Crit Care Med. 2006;174(1):67\u201374.","journal-title":"Am J Respir Crit Care Med"},{"issue":"S4","key":"2227_CR10","doi-asserted-by":"publisher","first-page":"S245","DOI":"10.1542\/peds.2008-2952K","volume":"123","author":"MK Schroth","year":"2009","unstructured":"Schroth MK. Special considerations in the respiratory management of spinal muscular atrophy. Pediatrics. 2009;123(S4):S245-249.","journal-title":"Pediatrics"},{"key":"2227_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/00002060-199609000-00005","volume":"75","author":"A Lissoni","year":"1996","unstructured":"Lissoni A, Aliverti A, Molteni F, Bach JR. Spinal muscular atrophy: kinematic breathing analysis. Am J Phys Med Rehabil. 1996;75:332\u20139.","journal-title":"Am J Phys Med Rehabil"},{"issue":"6","key":"2227_CR12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/resp.12330","volume":"19","author":"B Fauroux","year":"2014","unstructured":"Fauroux B, Khirani S. Neuromuscular disease and respiratory physiology in children: putting lung function into perspective. Respirology. 2014;19(6):782\u201391.","journal-title":"Respirology"},{"issue":"9","key":"2227_CR13","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/archneur.59.9.1445","volume":"59","author":"ST Iannaccone","year":"2002","unstructured":"Iannaccone ST, Rabb K, Carman D, Gordon J, Harris K, Morton A, et al. Outcome measures for pediatric spinal muscular atrophy. Arch Neurol. 2002;59(9):1445\u201350.","journal-title":"Arch Neurol"},{"issue":"3","key":"2227_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.pmr.2008.04.006","volume":"19","author":"P Kaufmann","year":"2008","unstructured":"Kaufmann P, Iannaccone ST. Clinical trials in spinal muscular atrophy. Phys Med Rehabil Clin N Am. 2008;19(3):653\u201360.","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"8","key":"2227_CR15","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.nmd.2020.06.009","volume":"30","author":"S Wenninger","year":"2020","unstructured":"Wenninger S, Stahl K, Wirner C, Einvag K, Thiele S, Walter MC, et al. Utility of maximum inspiratory and expiratory pressures as a screening method for respiratory insufficiency in slowly progressive neuromuscular disorders. Neuromuscul Disord. 2020;30(8):640\u20138.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"2227_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/jnnp-2016-314292","volume":"88","author":"RI Wadman","year":"2017","unstructured":"Wadman RI, Stam M, Gijzen M, Lemmink HH, Snoeck IN, Wijngaarde CA, et al. Association of motor milestones, SMN2 copy and outcome in spinal muscular atrophy types 0\u20134. J Neurol Neurosurg Psychiatry. 2017;88(4):365\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"14","key":"2227_CR17","doi-asserted-by":"publisher","first-page":"e1988","DOI":"10.1212\/WNL.0000000000010540","volume":"95","author":"CA Wijngaarde","year":"2020","unstructured":"Wijngaarde CA, Stam M, Otto LAM, Bartels B, Asselman FL, van Eijk RPA, et al. Muscle strength and motor function in adolescents and adults with spinal muscular atrophy. Neurology. 2020;95(14):e1988-1998.","journal-title":"Neurology"},{"issue":"4","key":"2227_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"2227_CR19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","volume":"52","author":"K Zerres","year":"1995","unstructured":"Zerres K, Sch\u00f6neborn SR. Natural history in proximal spinal muscular atrophy: clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol. 1995;52(5):518\u201323.","journal-title":"Arch Neurol"},{"issue":"7","key":"2227_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/thx.39.7.535","volume":"39","author":"SH Wilson","year":"1984","unstructured":"Wilson SH, Cooke NT, Edwards RHT, Spiro SG. Predicted normal values for maximal respiratory pressures in caucasian adults and children. Thorax. 1984;39(7):535\u20138.","journal-title":"Thorax"},{"issue":"5 Suppl","key":"2227_CR21","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.1097\/00002060-199509001-00009","volume":"74","author":"GT Carter","year":"1995","unstructured":"Carter GT, Abresch RT, Fowler WM, Johnson ER, Kilmer DD, McDonald CM. Spinal muscular atrophy. Am J Phys Med Rehabil. 1995;74(5 Suppl):S150-159.","journal-title":"Am J Phys Med Rehabil"},{"issue":"3","key":"2227_CR22","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1378\/chest.128.3.1524","volume":"128","author":"GAF Fregonezi","year":"2005","unstructured":"Fregonezi GAF, Resqueti VR, G\u00fcell R, Pradas J, Casan P, Augusto De Freitas Fregonezi G, et al. Effects of 8-week, interval-based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest. 2005;128(3):1524\u201330.","journal-title":"Chest"},{"issue":"6 Pt 1","key":"2227_CR23","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1164\/ajrccm.150.6.7952632","volume":"150","author":"F H\u00e9ritier","year":"1994","unstructured":"H\u00e9ritier F, Rahm F, Pasche P, Fitting JW. Sniff nasal inspiratory pressure: a noninvasive assessment of inspiratory muscle strength. Am J Respir Crit Care Med. 1994;150(6 Pt 1):1678\u201383.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2227_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1164\/ajrccm.159.1.9804052","volume":"159","author":"D Stefanutti","year":"1999","unstructured":"Stefanutti D, Fitting JW. Sniff nasal inspiratory pressure: reference values in Caucasian children. Am J Respir Crit Care Med. 1999;159(1):107\u201311.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2227_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rmed.2010.07.020","volume":"105","author":"M Koopman","year":"2011","unstructured":"Koopman M, Zanen P, Kruitwagen CLJJ, Van Der Ent CK, Arets HGM. Reference values for paediatric pulmonary function testing: the Utrecht dataset. Respir Med. 2011;105(1):15\u201323.","journal-title":"Respir Med"},{"issue":"Suppl 16","key":"2227_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1183\/09041950.005s1693","volume":"6","author":"PH Quanjer","year":"1993","unstructured":"Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;6(Suppl 16):5\u201340.","journal-title":"Eur Respir J"},{"issue":"6","key":"2227_CR27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/PHM.0b013e318174e4c7","volume":"87","author":"C Bianchi","year":"2008","unstructured":"Bianchi C, Baiardi P. Cough peak flows: standard values for children and adolescents. Am J Phys Med Rehabil. 2008;87(6):461\u20137.","journal-title":"Am J Phys Med Rehabil"},{"key":"2227_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/thoraxjnl-2012-201964","volume":"67","author":"J Hull","year":"2012","unstructured":"Hull J, Aniapravan R, Chan E, Chatwin M, Forton J, Gallagher J, et al. Guideline for respiratory management of children with neuromuscular disease. Thorax. 2012;67:1\u201340.","journal-title":"Thorax"},{"key":"2227_CR29","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1164\/rccm.166.4.518","volume":"166","author":"GJ Gibson","year":"2002","unstructured":"Gibson GJ, Whitelaw W, Siafakas N, Supinski GS, Fitting JW, Bellemare F, et al. American thoracic society\/European respiratory society ats\/ers statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166:518\u2013624.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2227_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319\u201338.","journal-title":"Eur Respir J"},{"key":"2227_CR31","first-page":"96","volume":"169","author":"H Kano","year":"2005","unstructured":"Kano H, Nakata H, Martin CF. Optimal curve fitting and smoothing using normalized uniform B-splines: a tool for studying complex systems. Appl Math Comput. 2005;169:96\u2013128.","journal-title":"Appl Math Comput"},{"key":"2227_CR32","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thoraxjnl-2012-201964","volume":"67","author":"J Hull","year":"2012","unstructured":"Hull J, Aniapravan R, Chan E, Chatwin M, Forton J, Gallagher J, et al. British Thoracic Society guideline for respiratory management of children with neuromuscular weakness. Thorax. 2012;67:i1\u201340.","journal-title":"Thorax"},{"key":"2227_CR33","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1053\/rmed.2000.0802","volume":"94","author":"H Hautmann","year":"2000","unstructured":"Hautmann H, Hefele S, Schotten K, Huber RM. Maximal inspiratory mouth pressures (PIMAX) in healthy subjects\u2014What is the lower limit of normal? Respir Med. 2000;94:689\u201393.","journal-title":"Respir Med"},{"issue":"15","key":"2227_CR34","doi-asserted-by":"publisher","first-page":"e1634","DOI":"10.1212\/WNL.0000000000009248","volume":"94","author":"CA Wijngaarde","year":"2020","unstructured":"Wijngaarde CA, Stam M, Otto LAM, Van Eijk RPA, Cuppen I, Veldhoen ES, et al. Population-based analysis of survival in spinal muscular atrophy. Neurology. 2020;94(15):e1634\u201344.","journal-title":"Neurology"},{"issue":"4","key":"2227_CR35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1474-4422(20)30037-5","volume":"19","author":"T Hagenacker","year":"2020","unstructured":"Hagenacker T, Wurster CD, G\u00fcnther R, Schreiber-Katz O, Osmanovic A, Petri S, et al. Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study. Lancet Neurol. 2020;19(4):317\u201325.","journal-title":"Lancet Neurol"},{"issue":"1","key":"2227_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13023-017-0598-0","volume":"12","author":"B Schoser","year":"2017","unstructured":"Schoser B, Fong E, Geberhiwot T, Hughes D, Kissel JT, Madathil SC, et al. Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature. Orphanet J Rare Dis. 2017;12(1):52.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"2227_CR37","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/ppul.24455","volume":"54","author":"N Kapur","year":"2019","unstructured":"Kapur N, Deegan S, Parakh A, Gauld L. Relationship between respiratory function and need for NIV in childhood SMA. Pediatr Pulmonol. 2019;54(11):1174\u201380.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"2227_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1183\/09031936.00050708","volume":"33","author":"B Fauroux","year":"2009","unstructured":"Fauroux B, Aubertin G, Cohen E, Cl\u00e9ment A, Lofaso F. Sniff nasal inspiratory pressure in children with muscular, chest wall or lung disease. Eur Respir J. 2009;33(1):113\u20137.","journal-title":"Eur Respir J"},{"issue":"7","key":"2227_CR39","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/00002060-200207000-00007","volume":"81","author":"AA Su\u00e1rez","year":"2002","unstructured":"Su\u00e1rez AA, Pessolano FA, Monteiro SG, Ferreyra G, Capria ME, Mesa L, et al. Peak flow and peak cough flow in the evaluation of expiratory muscle weakness and bulbar impairment in patients with neuromuscular disease. Am J Phys Med Rehabil. 2002;81(7):506\u201311.","journal-title":"Am J Phys Med Rehabil"},{"issue":"9","key":"2227_CR40","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/ppul.22688","volume":"48","author":"GM Buyse","year":"2013","unstructured":"Buyse GM, Goemans N, Van Den Hauwe M, Meier T. Effects of glucocorticoids and idebenone on respiratory function in patients with duchenne muscular dystrophy. Pediatr Pulmonol. 2013;48(9):912\u201320.","journal-title":"Pediatr Pulmonol"},{"issue":"11","key":"2227_CR41","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1136\/thx.2006.072884","volume":"62","author":"J Steier","year":"2007","unstructured":"Steier J, Kaul S, Seymour J, Jolley C, Rafferty G, Man W, et al. The value of multiple tests of respiratory muscle strength. Thorax. 2007;62(11):975\u201380.","journal-title":"Thorax"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02227-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02227-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02227-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T12:06:43Z","timestamp":1666613203000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02227-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2227"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02227-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-742225\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]},"assertion":[{"value":"22 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Medical Ethical Committee of the University Medical Center Utrecht approved this study (09-307\/NL29692.041.09) and informed consent was obtained from all participants and\/or their parents in case of minors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"W. Ludo van der Pol was member of the scientific advisory boards of Biogen and Avexis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}